Citations 11-20 of 42 total displayed.

Practice

Control of pain in adults with cancer: summary of SIGN guidelines

P J Cormie, M Nairn, J Welsh on behalf of the Guideline Development Group

BMJ 2008;337:a2154, doi: 10.1136/bmj.a2154, (Published 5 November 2008)

[Extract] [Full text]  

Practice

Prescribing intravenous immunoglobulin: summary of Department of Health guidelines

Drew Provan, Helen M Chapel, W A Carrock Sewell, Denise O’Shaughnessy on behalf of the UK Immunoglobulin Expert Working Group

BMJ 2008;337:a1831, doi: 10.1136/bmj.a1831, (Published 20 October 2008)

[Extract] [Full text]  

Practice

Commentary: Controversies in the Department of Health’s clinical guidelines for immunoglobulin use

Penny Fitzharris and Miriam Hurst

BMJ 2008;337:a1851, doi: 10.1136/bmj.a1851, (Published 20 October 2008)

[Extract] [Full text]  

Practice

Management of invasive meningococcal disease in children and young people: summary of SIGN guidelines

U Theilen, L Wilson, G Wilson, J O Beattie, S Qureshi, D Simpson on behalf of the Guideline Development Group

BMJ 2008;336:1367, doi: 10.1136/bmj.a129, (Published 14 June 2008)

[Extract] [Full text] [PDF]  

Practice

Commentary: Controversies in SIGN guidance on management of invasive meningococcal disease in children and young people

David Isaacs

BMJ 2008;336:1370, doi: 10.1136/bmj.a240, (Published 14 June 2008)

[Extract] [Full text] [PDF]  

Practice

Management of type 2 diabetes: summary of updated NICE guidance

Philip Home, Jonathan Mant, Jose Diaz, Claire Turner on behalf of the Guideline Development Group

BMJ 2008;336:1306, doi: 10.1136/bmj.39560.442095.AD, (Published 7 June 2008)

[Extract] [Full text] [PDF]  

Practice

Commentary: controversies in NICE guidance on management of type 2 diabetes

Stephen Atkin and Christopher Walton

BMJ 2008;336:1308, doi: 10.1136/bmj.39581.495069.AD, (Published 7 June 2008)

[Extract] [Full text] [PDF]  

Practice

Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance

Angela Cooper, Norma O’Flynn on behalf of the Guideline Development Group

BMJ 2008;336:1246, doi: 10.1136/bmj.39554.624086.AD, (Published 31 May 2008)

[Extract] [Full text] [PDF]  

Practice

Commentary: Controversies in NICE guidance on lipid modification for the prevention of cardiovascular disease

Francesco P Cappuccio

BMJ 2008;336:1248, doi: 10.1136/bmj.39580.424352.AD, (Published 31 May 2008)

[Extract] [Full text] [PDF]  

Practice

Prophylaxis against infective endocarditis: summary of NICE guidance

Roberta Richey, David Wray, Tim Stokes on behalf of the Guideline Development Group

BMJ 2008;336:770, doi: 10.1136/bmj.39510.423148.AD, (Published 5 April 2008)

[Extract] [Full text] [PDF]